Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

OctPM pathway control state

From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.


high-resolution terminology - matching measurements at high-resolution


OctPM pathway control state

Description

OctPM: Octanoylcarnitine & Pyruvate & Malate.

MitoPathway control state: FN

SUIT protocol: SUIT-002, SUIT-005

This substrate combination supports N-linked flux which is typically higher than FAO capacity (F/FN<0 in the OXPHOS state). In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare malate-anaplerotic pathway control state, M alone), and pyruvate is added to compare FAO as the background state with FN as the reference state.

Abbreviation: OctPM

Reference: MiPNet21.06 SUIT RP

More details
ยป FN
ยป Additive effect of convergent electron flow
ยป Respiratory complexes - more than five
ยป OctPGM pathway control state
ยป Convergent electron flow

OctPML

FN pathway in the LEAK state can be evaluated in the following SUIT protocols:

OctPMP

FN pathway in the OXPHOS state can be evaluated in the following SUIT protocols:


OctPME

FN pathway in the ET state can be evaluated in the following SUIT protocols:



1PM;2D;3U;4G;5S;6Oct;7Rot;8Gp-


SUIT RP2



MitoPedia concepts: SUIT state